Latin America Vaccine Market Report and Forecast 2023-2028
Market Report I 2023-10-20 I 158 Pages I EMR Inc.
Latin America Vaccine Market Report and Forecast 2023-2028
Market Outlook
According to the report by Expert Market Research (EMR), the Latin America vaccine market reached a value of approximately USD 4.87 billion in 2022. Aided by the support of the rising awareness about immunisation and the growing application of vaccines in various healthcare settings, the market is projected to further grow at a CAGR of 7.10% between 2023 and 2028 to reach a value of USD 7.35 billion by 2028.
Vaccines play a vital role in public health, offering protection against numerous infectious diseases and thus contributing to improved health and lifespan. The growing need for immunisation programs, increased government funding for vaccinations, and advancements in vaccine development technologies are driving the vaccine market in Latin America.
The increasing awareness about the importance of immunisation is one of the key factors driving the Latin America vaccine market growth. With the growing knowledge of the health benefits associated with vaccination, such as disease prevention and herd immunity, there has been a significant shift towards increased vaccination rates, leading to a surge in demand for various vaccines.
Additionally, the global health crisis due to COVID-19 has highlighted the importance of vaccines and accelerated the development, approval, and distribution of COVID-19 vaccines. This has not only increased the demand for COVID-19 vaccines but also underscored the need for routine immunisation against other infectious diseases, further propelling the vaccine market.
The application of vaccines in various healthcare settings is another factor contributing to the Latin America vaccine market development. Vaccines are integral to paediatric health, travel medicine, and infectious disease control, among other fields. Moreover, advancements in vaccine development technologies and platforms have enabled the production of novel vaccines and improved the efficacy and safety profile of existing ones.
Further, the growing commitment of governments in Latin America to improve public health and reduce the burden of preventable diseases has led to increased funding and implementation of comprehensive immunisation programs. These initiatives, coupled with the rise in public-private partnerships for vaccine research and development, are expected to boost the Latin America vaccine market demand.
Lastly, the evolving disease landscape and the emergence of new pathogens have highlighted the need for ongoing vaccine research and development. In response to these challenges, the vaccine industry is focusing on innovative approaches, such as mRNA technologies and viral vector platforms, to develop effective vaccines rapidly, thus boosting the Latin America vaccine market expansion.
Market Segmentation
The market can be divided based on technology, indication, end user, and country.
Market Breakup by Technology
- Recombinant and Conjugate Vaccine
- Inactivated Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Others
Market Breakup by Indication
- Pneumococcal Disease
- Influenza
- Human Papilloma Virus
- Meningococcal Disease
- Rotavirus
- Varicella, Measles, Mumps, and Rubella
- Diphtheria, Pertussis, and Tetanus (DPT)
- Polio
- Hepatitis
- JE (Japanese Encephalitis) Vaccine
- Others
Market Breakup by End User
- Paediatric Vaccine
- Adult Vaccine
- Travellers Vaccine
Market Breakup by Country
- Brazil
- Argentina
- Mexico
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the Latin America vaccine companies. Some of the major key players explored in the report by Expert Market Research are as follows:
- GlaxoSmithKline plc
- Novartis AG
- Pfizer Laboratories Ltd
- Sanofi
- AstraZeneca plc.
- Others
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 Global Vaccine Market Overview
8.1 Key Industry Highlights
8.2 Global Vaccine Historical Market (2018-2022)
8.3 Global Vaccine Market Forecast (2023-2028)
9 Latin America Vaccine Market Analysis
9.1 Key Industry Highlights
9.2 Latin America Vaccine Historical Market (2018-2022)
9.3 Latin America Vaccine Market Forecast (2023-2028)
10 Latin America Vaccine Market by Technology
10.1 Recombinant and Conjugate Vaccine
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Inactivated Vaccines
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 Live Attenuated Vaccines
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Toxoid Vaccines
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Latin America Vaccine Market by Indication
11.1 Pneumococcal Disease
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Influenza
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 Human Papilloma Virus
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 Meningococcal Disease
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Rotavirus
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Varicella, Measles, Mumps, and Rubella
11.6.1 Market Share
11.6.2 Historical Trend (2018-2022)
11.6.3 Forecast Trend (2023-2028)
11.7 Diphtheria, Pertussis, and Tetanus (DPT)
11.7.1 Market Share
11.7.2 Historical Trend (2018-2022)
11.7.3 Forecast Trend (2023-2028)
11.8 Polio
11.8.1 Market Share
11.8.2 Historical Trend (2018-2022)
11.8.3 Forecast Trend (2023-2028)
11.9 Hepatitis
11.9.1 Market Share
11.9.2 Historical Trend (2018-2022)
11.9.3 Forecast Trend (2023-2028)
11.10 JE (Japanese Encephalitis) Vaccine
11.10.1 Market Share
11.10.2 Historical Trend (2018-2022)
11.10.3 Forecast Trend (2023-2028)
11.11 Others
12 Latin America Vaccine Market by End User
12.1 Paediatric Vaccine
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Adult Vaccine
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Travellers Vaccine
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
13 Latin America Vaccine Market by Country
13.1 Brazil
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 Argentina
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Mexico
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter's Five Forces Analysis
14.2.1 Supplier's Power
14.2.2 Buyer's Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 GlaxoSmithKline plc
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Novartis AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Pfizer Laboratories Ltd
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Sanofi
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 AstraZeneca plc.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America Vaccine Market: Key Industry Highlights, 2018 and 2028
2. Latin America Vaccine Historical Market: Breakup by Technology (USD Million), 2018-2022
3. Latin America Vaccine Market Forecast: Breakup by Technology (USD Million), 2023-2028
4. Latin America Vaccine Historical Market: Breakup by Indication (USD Million), 2018-2022
5. Latin America Vaccine Market Forecast: Breakup by Indication (USD Million), 2023-2028
6. Latin America Vaccine Historical Market: Breakup by End User (USD Million), 2018-2022
7. Latin America Vaccine Market Forecast: Breakup by End User (USD Million), 2023-2028
8. Latin America Vaccine Historical Market: Breakup by Country (USD Million), 2018-2022
9. Latin America Vaccine Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Latin America Vaccine Market Structure
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.